• 1
    Harvey AS, Nolan T, Carlin JB. Community-based study of mortality in children with epilepsy. Epilepsia 1993;34:597603.
  • 2
    Sillanpää M. Medico-social prognosis of children with epilepsy. Acta Paediatr Scand 1973;(suppl 237):1104.
  • 3
    Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia 1991;32:42945.
  • 4
    Kurokawa T, Fung KC, Hanai T, Goya N. Mortality and clinical features in cases of death among epileptic children. Brain Dev 1982;4:3215.
  • 5
    Brorson LO, Wranne L. Long-term prognosis in childhood epilepsy: survival and seizure prognosis. Epilepsia 1987;28:32430.
  • 6
    Matsumoto A, Watanabe K, Sugiura M, Negoro T, Takaesu E, Iwase K. Long-term prognosis of convulsive disorders in the first year of life: mental and physical development and seizure persistence. Epilepsia 1983;24:3219.
  • 7
    Towne AR, Pellock JM, Ko D, De Lorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:2734.
  • 8
    Driscoll SM, Jack RL, Teasley JE, Towne AR, Pellock JM, De-Lorenzo RJ. Mortality in childhood status epilepticus [Abstract]. Ann Neurol 1988;24:318.
  • 9
    Siemes H, Nau H, Schultze K, et al. Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity. Epilepsia 1993;34:33246.
  • 10
    Asconape JJ, Penry JK, Dreifuss FE, Riela A, Mirza W. Valproate-associated pancreatitis. Epilepsia 1993;34:17783.
  • 11
    Baruzzi A, Michellucci R, Tassinari CA. Benzodiazepines nitrazepam. In: LevyR, MattsonR, MeldrumB, PenryJK, DreifussFE, eds. Antiepileptic drugs. 3rd ed. New York : Raven Press, 1989:785803.
  • 12
    Murphy JV, Saeasky F, Marquart KM, Harris DJ. Deaths in young children receiving nitrazepam. J Pediatr 1987;111:1457.
  • 13
    Wyllie E, Wyllie R, Cruse RP, Rothner AD, Eremberg G. The mechanism of nitrazepam induced drooling and aspiration. N Engl J Med 1986;314:358.
  • 14
    Lim HC, Nigro MA, Beierwaltes P, Tolia V, Wishnow R. Nitrazepam-induced cricopharyngeal dysphagia, abnormal esophageal peristalsis and associated bronchospasm: probable cause of nitrazepam-related sudden death. Brain Dev 1992;14:30914.
  • 15
    Benassi E, Bo GP, Cocito L, Maffini M, Loeb C. Carbamazepine and cardiac conduction disturbances. Ann Neurol 1987;22:2801.
  • 16
    Leestma JE, Kalelkar MB, Teas SS, Jay GW, Hughes JR. Sudden unexpected death associated with seizures: analysis of 66 cases. Epilepsia 1984;25:848.
  • 17
    Jay GW, Leesma JE. Sudden death in epilepsy: a comprehensive review of the literature and proposed mechanisms. Acta Neurol Scand 1981;63(suppl 82):166.
  • 18
    Earnest MP, Thomas GE, Eden RA, Hossack KF. The sudden unexplained death syndrome in epilepsy: demographic, clinical, and postmortem features. Epilepsia 1992;33:3106.
  • 19
    Leestma JE, Walczak T, Hughes JR, Kalelkar MB, Teas SS. A prospective study on sudden unexpected death in epilepsy. Ann Neurol 1989;26:195203.
  • 20
    Jeavons PM. Choice of drug therapy in epilepsy. Practitioner 1977;219:54256.
  • 21
    Kenny RA, Kafetz K, Cox M, Timmers J. Impaired nitrazepam metabolism in hypothyroidism. Postgrad Med 1984;60:2967.
  • 22
    Rintahaka PJ. Sudden infant death syndrome in Finland in 1969–80: an epidemiological study. Health Education: Series Original Reports 3/1985. Helsinki: National Board of Health, Finland, 1985.